Common Myths About Alopecia Areata
6.8 million people in the U.S. are affected by alopecia areata. Alopecia is an autoimmune skin disorder that causes hair loss on the scalp, face, and other areas of the body. Many things are still unknown about it, including the cause, which makes people’s minds wander with mystery. Although there is still a lot to […]
How to Keep Your Skin Glowing this Holiday Season
If you are in disbelief that the holiday season is already upon us, you are not alone. From the family gatherings to delicious feasts we will all soon take part in; it is easy to get caught up and forget how stressful the holiday season can be. These effects can last long after the holidays, […]
Pyoderma Gangrenosum
1 in every 100,000 people in the U.S. has pyoderma gangrenosum. Pyoderma can look like a variety of conditions and can delay proper diagnosis and treatment. Knowing the signs and risk factors can help those who suffer from it avoid serious complications. Although the exact cause is unknown, clinical research is paving the way for […]
How Do I Know If I Have Alopecia Areata?
The unpredictable hair loss and regrowth of alopecia areata can be challenging, and the symptoms can mimic other conditions. So, how do you know for sure you have it? A diagnosis can only be made by a physician, such as a dermatologist. However, by knowing the symptoms and causes, you can be on your way […]
Psoriatic Arthritis Classifications
Psoriatic arthritis (PsA) is a chronic autoimmune disease that affects millions every year. It can be diagnosed at any age, though it is most common between the ages of 30 and 50. There is no cure for PsA and the damage caused can be permanent, if not caught and treated early. Finding the right treatment […]
ForCare Clinical Research is Fastest to Get Meds to Market
TAMPA, Fla. – ForCare Clinical Research has been named a winner of the 2019 ACRP-Devana Solutions Site Metric Challenge Study, declared number one – in a field of nearly 200 – in the category of “Fastest from Activation to First Screen.” “We appreciate the recognition of this achievement, as getting new therapies with reasonable safety […]
